The FDA’s draft guidance on accelerated approval of drugs and biologics discusses the timely conduct of confirmatory trials as well as aspects of confirmatory trial design. The draft guidance, released Dec. 6, notes that for drugs granted accelerated approval, sponsors must conduct post-approval confirmatory trials to verify and describe the effect on irreversible morbidity o... Read More